Pharma Informatics & Services Investment Banking

Expertise to navigate a complex field.

The Raymond James Pharma Informatics and Services team, located in both the U.S and Europe, focuses on pharmaceutical and biotechnology companies at the forefront of innovation, providing a full range of financing and advisory services. Our skills and expertise turn complex scientific topics into messages that grab investor attention in a competitive field. We understand the challenges companies face, such as designing a better model for the discovery and testing of innovative new drugs to gain fast approvals and a higher success rate. The increasing complexity of clinical trials, trial designs and procedures, advances in personalized medicine, the spread of outsourcing, the mounting requirements for data, and the difficulty of recruiting patient peers are on our radar as well. This knowledge, together with our hands-on approach to each transaction and strong execution capabilities, provides an advantage in an ever-changing sector.

Pharma Informatics & Services Subsector Expertise

  • Contract Research Organizations
  • Contract Development and Manufacturing Organizations
  • Technology Solutions for Life Sciences
  • Technology-Enabled Services for Life Sciences

Senior Banking Team

Bio-no-photo
Jack Jeong
Senior Vice President
Nashville
   
Read Bio
Sebastian Wintgens
Sebastian Wintgens
Senior Vice President
Munich
   
Read bio
Bio-no-photo
Clayton Wilson
Vice President
Chicago
   
Read Bio

Transaction History

Transaction history may include a transaction completed by a Raymond James banker while at a former firm.

Recent News

Investment Banking  |  June 5, 2017
Raymond James grows Financial Services Investment Banking practice with addition of depository institutions-focused banker

View Press Release
Investment Banking  |  May 31, 2017
Raymond James strengthens Global Healthcare Team with Konrad Hinkens

View Press Release
Investment Banking  |  May 30, 2017
Strengthened by an experienced investment banker: Joachim Beickler joins the Advisory Board at Raymond James

View Press Release